Cellosaurus logo
expasy logo

Cellosaurus 3C5 [Mouse hybridoma against human PSCA] (CVCL_B0TR)

[Text version]
Cell line name 3C5 [Mouse hybridoma against human PSCA]
Accession CVCL_B0TR
Resource Identification Initiative To cite this cell line use: 3C5 [Mouse hybridoma against human PSCA] (RRID:CVCL_B0TR)
Comments Group: Patented cell line.
Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-12616.
Monoclonal antibody isotype: IgG2a, kappa.
Monoclonal antibody target: UniProtKB; O43653; Human PSCA.
Species of origin Mus musculus (Mouse) (NCBI Taxonomy: 10090)
Hierarchy Parent: CVCL_D145 (HL-1 Friendly Myeloma-653)
Category Hybridoma
Publications

PubMed=10713670; DOI=10.1038/sj.onc.1203426
Zhen-Nan Gu, George V. Thomas, Joyce Yamashiro, Itsushi Peter Shintaku, Fred Dorey, Arthur B. Raitano, Owen Neil Witte, Jonathan William Said, Massimo Loda, Robert E. Reiter;
Prostate stem cell antigen (PSCA) expression increases with high Gleason score, advanced stage and bone metastasis in prostate cancer.
Oncogene 19:1288-1296(2000)

PubMed=11226295; DOI=10.1073/pnas.051624698; PMCID=PMC30194
Douglas C. Saffran, Arthur B. Raitano, Rene S. Hubert, Owen Neil Witte, Robert E. Reiter, Aya Jakobovits;
Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.
Proc. Natl. Acad. Sci. U.S.A. 98:2658-2663(2001)

Patent=US8524460
Robert E. Reiter, Owen Neil Witte;
PSCA: prostate stem cell antigen and uses thereof.
Patent number US8524460, 03-Sep-2013

Cross-references
Encyclopedic resources Wikidata; Q108819587
Entry history
Entry creation23-Sep-2021
Last entry update21-Mar-2023
Version number3